Terumo Blood and Cell Technologies (Terumo BCT) has announced funding support for a multi-center clinical trial aimed at reducing complications from acute chest syndrome (ACS) in adult patients with sickle cell disease (SCD). Researchers at Henri Mondor University Hospital in France will lead the trial, known as ARCAD, to evaluate the efficacy and safety of…